Lachmann_Lab retweeted
Our #openscience paper describing our #iPSC training school is published. 31 researchers from accross europe were trained in #iPSC techniques @RCSI_Irl. Video protocols in paper.
@SchweikertAnja @LabHurley @drnadianathan @ChiaraDeSanti3 @COSTprogramme stemcellres.biomedcentral.co…
Lachmann_Lab retweeted
Mitochondrial function in macrophages controls cardiac repair after myocardial infarction:
buff.ly/3ka2YVH
David Weissman & @ChristophMaack highlight the metabolic mechanism by which macrophages regulate cardiac repair following myocardial infarction; #Commentary
Lachmann_Lab retweeted
Last call for action: early bird tickets and the submission of abstracts for oral presentations for the GSCN Conference & 20 Years @StemCellsNRW
from 13-16.9.22 in Münster. The deadline is 24 June! Save your spot in the program: gscn-conferences.org #stemcells #stammzellen
Lachmann_Lab retweeted
GSCN Magazine “Stem Cell Research & Diseases III” with the topics Hematopoiesis and blood diseases/Fresh blood from the lab/Modeling diseases of brain and mind/Cell replacement therapy for Parkinson and more, is online gscn.org/german-stem-cell-ne…. Find a moment to flip through.
Lachmann_Lab retweeted
#EMDS deadlines approaching!⏳Apply for #EMDS young investigator award until July 10th! More info here 👉macrophage.de/?page_id=102
Register for the conference until May 31st for early bird registration: emds2022.com @EuMacDcSoc @LabSchlitzer @ImmunoSens @LabGarbi
Pls RT
Lachmann_Lab retweeted
Researchers with the #HumanCellAtlas consortium report a major feat: the creation of detailed maps of more than a million individual cells across 33 organs, representing the most comprehensive, cross-tissue cell atlases to date.
Learn more in Science. ➡ fcld.ly/23zpp4g
Lachmann_Lab retweeted
#Monocytes transition to #macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2. New study from Vijayashree Mysore, Suhail Tahir, Kazuhiro Furuhashi, Tanya N. Mayadas and colleagues @BWHPath: bit.ly/3JutjVk
#InnateImmunity #inflammation
Lachmann_Lab retweeted
9 days and counting until the First Annual Myeloid Network Symposium!
Announcing our incredible keynote and invited speakers @IdoAmitLab @MiriamMerad @FGinhoux @mk_ruhland!
Join us March 10th 9am-3pm ET.
Zoom link and full schedule: themyeloidnetwork.eng.ucsd.e…
Lachmann_Lab retweeted
Improved glycemic control after transplantation of human pluripotent stem-cell-derived islets for #diabetes treatment in non-human primates nature.com/articles/s41591-0…
Lachmann_Lab retweeted
New data showing the global burden of AMR is a wake up call to make progress on AMR.
Read my article on the global need for multilateral action, public engagement, and private sector leadership ⤵️
ft.com/content/da746047-ecbc…
Lachmann_Lab retweeted
RESIST is using Twitter😀! Greetings to our members, research groups, partner institutions @LachmannLab, @SarinaRavens, @AViejoBorbolla, @GeroldLab, @t_pietschmann, @mgalactus, @bosse_lab, @DanDepledge, @beatesodeik, @KalinkeUlrich, @ExpVirology, @TWINCOREtweets, @Helmholtz_HZI
Lachmann_Lab retweeted
ICYMI: Read how Abdin et al review the current status of the role of macrophages in cancer therapy in this new #JITC review. #ESMO21 ow.ly/kat750GbpcR
Lachmann_Lab retweeted
New Article online now CellStemCell: Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy zpr.io/4Y9g2QG3UGDW
Lachmann_Lab retweeted
📣Call for young group leaders (<8 & 12 years post PhD) at @institutpasteur
You work on #immunotherapy and #cancer, novel #vaccine approaches, #microbiome in human health, #singlecell biology? Come and join our department!
For more info on this call⬇️ research.pasteur.fr/fr/call/…
Lachmann_Lab retweeted
Research from @UCSanDiego, published in @StemCellsJournl, demonstrates potential therapeutic applications of iPSC-derived #macrophages in treating liver fibrosis in mice. #iPSC #celltherapy
bit.ly/3n6JRed
Lachmann_Lab retweeted
.@gschwend_julia, @ChSchneider_PhD @UZH_en and colleagues unveil AT2s as a constitutive and dominant source of GM-CSF in the alveolar niche, nurturing alveolar macrophages in prenatal as well as postnatal stages of lung development. bit.ly/3ybjLJb
#InnateImmunity
Lachmann_Lab retweeted
New #JITC short report: CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies ow.ly/2oYM50G19c1
Lachmann_Lab retweeted
MHH-Studie zu #SARSCoV2: Kombination der Impfstoffe von AstraZeneca und Biontech/Pfizer schützt besonders gut – auch bei Virusvarianten: corona.mhh.de/corona-news-au…
#DZIF_Wissenschaftler_innen #Kreuzimpfung #COVID19
Lachmann_Lab retweeted
S100A8/A9 is the first predictive marker for #neonatal #sepsis @Wiley_Health @LabSchultze #UlasThomas #MedHochschHannover #serum S100A8/A9 #LOS #childhood #mortality bit.ly/3u9b3K9




























